Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
CompletedOBSERVATIONAL
Enrollment
977
Participants
Timeline
Start Date
September 23, 2020
Primary Completion Date
December 21, 2023
Study Completion Date
April 29, 2024
Conditions
Nonvalvular Atrial Fibrillation
Trial Locations (1)
75013
Geriatric Department, Broca Hospital, Paris
All Listed Sponsors
lead
Gérond'if
OTHER
NCT04586972 - Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study; | Biotech Hunter | Biotech Hunter